These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11184046)

  • 1. Medication use evaluation: a work in progress.
    Schrand LM; Behmer-Miller KA; Ross MB; Mutnick AH
    Pharm Pract Manag Q; 2000 Jul; 20(2):1-15. PubMed ID: 11184046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to develop a successful DUE (drug usage evaluation) program: experience of a teaching medical center.
    Cheung MO
    Hosp Formul; 1994 Feb; 29(2):137-9, 142-3, 145. PubMed ID: 10131876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulary management at a tertiary care teaching hospital.
    Mutnick AH; Ross MB
    Pharm Pract Manag Q; 1997 Apr; 17(1):63-87. PubMed ID: 10166245
    [No Abstract]   [Full Text] [Related]  

  • 5. The integration of quality assessment and a patient-specific intervention/outcomes program.
    Mutnick AH; Sterba KJ; Szymusiak-Mutnick BA
    Pharm Pract Manag Q; 1998 Jan; 17(4):25-36. PubMed ID: 10174746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target drug monitoring: a cost-effective service provided by staff pharmacists.
    Chrymko MM; Meyer JD; Kelly WN
    Hosp Pharm; 1994 Apr; 29(4):347, 350-2. PubMed ID: 10133463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication use review process and information systems utilized for oncology chemotherapy quality improvement.
    Bourret JA; Demers RF; Wordell D; Irani M; Baker J; Evangelista C
    Pharm Pract Manag Q; 1996 Apr; 16(1):1-17. PubMed ID: 10157736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influencing prescribing practices and associated outcomes utilizing the drug use evaluation process.
    Sloan NE; Peroutka JA; Morgan DE; Ross MB; Mutnick AH
    Top Hosp Pharm Manage; 1994 Oct; 14(3):1-12. PubMed ID: 10138923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization.
    Sun SX; Lee KY; Bertram CT; Goldstein JL
    Curr Med Res Opin; 2007 Aug; 23(8):1859-66. PubMed ID: 17605893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of an aminoglycoside order review process in a central dispensary.
    Zelenitsky SA; Richard A
    Can J Hosp Pharm; 1993 Dec; 46(6):269-74. PubMed ID: 10131345
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparing for hospital accreditation surveys.
    Hayman AC
    Radiol Manage; 1987; 9(3):27-9. PubMed ID: 10302233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A blueprint for antibiotic utilization review.
    Leist ER
    Hosp Med Staff; 1981 May; 10(5):19-24. PubMed ID: 10251098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive education plan: the key to a successful Joint Commission on Accreditation of Healthcare Organizations survey.
    Thurber R; Read LE
    J Nurses Staff Dev; 2008; 24(3):129-32. PubMed ID: 18525416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lean sigma--will it work for healthcare?
    Bahensky JA; Roe J; Bolton R
    J Healthc Inf Manag; 2005; 19(1):39-44. PubMed ID: 15682675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician-administrator collaboration slows hospital cost increases.
    Hofmann PB
    Hosp Prog; 1983 Jul; 64(7):60-3, 72. PubMed ID: 10261731
    [No Abstract]   [Full Text] [Related]  

  • 17. Establishing a hospital program to improve antimicrobial use, control bacterial resistance and contain healthcare costs: the University of Louisville experience.
    Arnold FW; Patel A; Nakamatsu R; Smith RS; Newman D; Sciortino CV; Peyrani P; Snyder J; Schulz P; Ramirez JA
    J Ky Med Assoc; 2007 Sep; 105(9):431-7. PubMed ID: 17941421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can a multidisciplinary initiative to increase adverse drug reaction reporting work?
    Perkerson KA; Quercia RA; Goldman M; Goddu G; Coleman CI
    Conn Med; 2004 May; 68(5):281-4. PubMed ID: 15171264
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost improvement program generates major savings.
    Peterson RR
    Hospitals; 1978 Jul; 52(13):83-4, 86, 88-90. PubMed ID: 658917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors: a better prescription is needed.
    Khara HS; Pitchumoni CS
    J Clin Gastroenterol; 2009 Jul; 43(6):597-8. PubMed ID: 19384247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.